Insiders Poseida Therapeutics, Inc.

Equities

PSTX

US73730P1084

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-15 pm EDT			5-day change	1st Jan Change
3.46 ^USD	+18.49%		+27.68%	+2.98%

May. 14	Poseida Therapeutics Q1 Net Loss Narrows, Revenue Rises	MT
May. 14	Earnings Flash (PSTX) POSEIDA THERAPEUTICS Reports Q1 Revenue $28.1M	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Poseida Therapeutics Appoints Syed Rizvi as Chief Medical Officer	Mar. 25	MT
Poseida Therapeutics, Inc Appoints Syed Rizvi as Chief Medical Officer Effective April 1, 2024	Mar. 25	CI
Poseida Therapeutics, Inc. Announces Executive Changes	Mar. 07	CI
Poseida Therapeutics, Inc. Announces Board Changes	23-10-10	CI
Poseida Therapeutics, Inc. Announces Chief Executive Officer Changes	23-10-10	CI
Poseida Therapeutics Names Kristin Yarema as CEO, Mark Gergen as Executive Chairman	23-10-09	MT
Poseida Therapeutics, Inc. Appoints Kristin Yarema as President, Cell Therapy	23-04-12	CI
Poseida Therapeutics, Inc. Appoints Five New Members to Its Gene Therapy Scientific Advisory Board	23-03-01	CI
Poseida Therapeutics Executive Chairman Resigns; Shares Fall After-Hours	23-01-31	MT
Poseida Therapeutics, Inc. Announces Resignation of Eric Ostertag as Executive Chairman and Retirement from the Board of Directors, Effective February 3, 2023	23-01-31	CI
Poseida Therapeutics, Inc. Announces Appointment of George M. Church as Chair of Gene Therapy Scientific Advisory Board	22-07-26	CI
Poseida Therapeutics Appoints Charles M. Baum to Board of Directors	22-05-18	CI
Matthew Spear Informs Poseida Therapeutics, Inc. of His Intent to Resign from Chief Medical Officer Position, Effective April 22, 2022	22-04-07	CI
Poseida Therapeutics Appoints Brent Warner as President, Gene Therapy	22-02-22	CI
Poseida Therapeutics President Mark Gergen Named CEO, Wll Succeed Eric Ostertag in February	22-01-10	MT
Poseida Therapeutics, Inc. Announces Executive Changes	22-01-10	CI
Poseida Therapeutics Announces Mark Gergen as Chief Executive Officer, Effective February 1, 2022	22-01-10	CI
Poseida Therapeutics : Promotes Johanna Mylet to Finance Chief	21-10-13	MT
Poseida Therapeutics Announces Leadership Appointments	21-10-13	CI
Poseida Therapeutics Announces Leadership Appointments	21-10-13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Poseida Therapeutics, Inc.

Equities

PSTX

US73730P1084

Insiders

Filters